Buccal Drug Delivery Systems Market Size, Share & Trends Report

Buccal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Buccal Tablets & Lozenges), By Application (Pain Management, Smoking Cessation, Angina Pectoris), By End-use, By Region, And Segment Forecast, 2024 - 2030

  • Report ID: GVR-4-68038-397-3
  • Number of Report Pages: 120
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                        1.3.1. Information Procurement
                        1.3.2. Information or Data Analysis
                        1.3.3. Market Formulation & Data Visualization
                        1.3.4. Data Validation & Publishing
                    1.4. Research Scope and Assumptions
                        1.4.1. List of Data Sources
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Buccal Drug Delivery Systems Market Variables, Trends, & Scope
                    3.1. Market Introduction/Lineage Outlook
                    3.2. Market Size and Growth Prospects (USD Million)
                    3.3. Market Dynamics
                        3.3.1. Market Drivers Analysis
                        3.3.2. Market Restraints Analysis
                    3.4. Buccal Drug Delivery Systems Market Analysis Tools
                        3.4.1. Porter’s Analysis
                            3.4.1.1. Bargaining power of the suppliers
                            3.4.1.2. Bargaining power of the buyers
                            3.4.1.3. Threats of substitution
                            3.4.1.4. Threats from new entrants
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Economic and Social landscape
                            3.4.2.3. Technological landscape
                            3.4.2.4. Environmental landscape
                            3.4.2.5. Legal landscape
Chapter 4. Buccal Drug Delivery Systems Market: Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Buccal Drug Delivery Systems Market: Solution Movement Analysis, 2023 & 2030 (USD Million)
                    4.3. Sublingual Films
                        4.3.1. Sublingual Films And Wafers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.4. Buccal Tablets/Lozenges
                        4.4.1. Buccal Tablets/Lozenges Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Oral Sprays
                        4.5.1. Oral Sprays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Buccal Drug Delivery Systems Market: Application Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Buccal Drug Delivery Systems Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
                    5.3. Pain Management
                        5.3.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.4. Smoking Cessation
                        5.4.1. Smoking Cessation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Angina Pectoris
                        5.5.1. Angina Pectoris Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Others
                        5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Buccal Drug Delivery Systems Market: End Use Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Buccal Drug Delivery Systems Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
                    6.3. Hospitals
                        6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.4. Ambulatory Centers
                        6.4.1. Ambulatory Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Others (Clinics, Home Health/OTC)
                        6.5.1. Others (Clinics, Home Health/OTC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Buccal Drug Delivery Systems Market: Regional Estimates & Trend Analysis
                    7.1. Buccal Drug Delivery Systems Market Share, By Region, 2023 & 2030, USD Million
                    7.2. North America
                        7.2.1. North America Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.2.2. U.S.
                            7.2.2.1. U.S. Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.2.3. Canada
                            7.2.3.1. Canada Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.2.4. Mexico
                            7.2.4.1. Mexico Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.3. Europe
                        7.3.1. Europe Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.2. UK
                            7.3.2.1. UK Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.3. Germany
                            7.3.3.1. Germany Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.4. France
                            7.3.4.1. France Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.5. Italy
                            7.3.5.1. Italy Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.6. Spain
                            7.3.6.1. Spain Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.7. Denmark
                            7.3.7.1. Denmark Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.8. Sweden
                            7.3.8.1. Sweden Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.9. Norway
                            7.3.9.1. Norway Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.4. Asia Pacific
                        7.4.1. Asia Pacific Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.2. China
                            7.4.2.1. China Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.3. Japan
                            7.4.3.1. Japan Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.4. India
                            7.4.4.1. India Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.5. Australia
                            7.4.5.1. Australia Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.6. South Korea
                            7.4.6.1. South Korea Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.7. Thailand
                            7.4.7.1. Thailand Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.5. Latin America
                        7.5.1. Latin America Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.5.2. Brazil
                           7.5.2.1. Brazil Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.5.3. Argentina
                            7.5.3.1. Argentina Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.6. Middle East and Africa
                        7.6.1. Middle East and Africa Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.2. South Africa
                            7.6.2.1. South Africa Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.3. Saudi Arabia
                            7.6.3.1. Saudi Arabia Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.4. UAE
                            7.6.4.1. UAE Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.5. Kuwait
                            7.6.5.1. Kuwait Buccal Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis by Key Market Participants
                    8.2. Company Categorization
                    8.3. Company Heat Map Analysis
                    8.4. Company Profiles
                        8.4.1. Teva Pharmaceutical Industries Ltd.
                            8.4.1.1. Participant’s Overview
                            8.4.1.2. Financial Performance
                            8.4.1.3. Product Benchmarking
                            8.4.1.4. Recent Developments/Strategic Initiatives
                        8.4.2. GSK plc
                            8.4.2.1. Participant’s Overview
                            8.4.2.2. Financial Performance
                            8.4.2.3. Product Benchmarking
                            8.4.2.4. Recent Developments/Strategic Initiatives
                        8.4.3. Pfizer Inc.
                            8.4.3.1. Participant’s Overview
                            8.4.3.2. Financial Performance
                            8.4.3.3. Product Benchmarking
                            8.4.3.4. Recent Developments/Strategic Initiatives
                        8.4.4. Generex Biotechnology Corporation (LUMITOS AG)
                            8.4.4.1. Participant’s Overview
                            8.4.4.2. Financial Performance
                            8.4.4.3. Product Benchmarking
                            8.4.4.4. Recent Developments/Strategic Initiatives
                        8.4.5. ARx, LLC.
                            8.4.5.1. Participant’s Overview
                            8.4.5.2. Financial Performance
                            8.4.5.3. Product Benchmarking
                            8.4.5.4. Recent Developments/Strategic Initiatives
                        8.4.6. Catalent, Inc
                            8.4.6.1. Participant’s Overview
                            8.4.6.2. Financial Performance
                            8.4.6.3. Product Benchmarking
                            8.4.6.4. Recent Developments/Strategic Initiatives
                        8.4.7. Collegium Pharmaceutical
                            8.4.7.1. Participant’s Overview
                            8.4.7.2. Financial Performance
                            8.4.7.3. Product Benchmarking
                            8.4.7.4. Recent Developments/Strategic Initiatives
                        8.4.8. Cynapsus Therapeutics Inc.
                            8.4.8.1. Participant’s Overview
                            8.4.8.2. Financial Performance
                            8.4.8.3. Product Benchmarking
                            8.4.8.4. Recent Developments/Strategic Initiatives
                        8.4.9. Endo, Inc.
                            8.4.9.1. Participant’s Overview
                            8.4.9.2. Financial Performance
                            8.4.9.3. Product Benchmarking
                            8.4.9.4. Recent Developments/Strategic Initiatives
                        8.4.10. Indivior PLC
                            8.4.10.1. Participant’s Overview
                            8.4.10.2. Financial Performance
                            8.4.10.3. Product Benchmarking
                            8.4.10.4. Recent Developments/Strategic Initiatives



What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon